2024 annual financial data
Rapport Therapeutics 2024 Operating margin
Rapport Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -83,055,000 USD and net income was -78,307,000 USD.
Operating cash flow was -64,828,000 USD.
Get free Rapport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -83,055,000 USD
- Net income
- -78,307,000 USD
- Operating cash flow
- -64,828,000 USD